Overview
This randomized, double-blind, placebo-controlled, will evaluate whether oral hyoscine butylbromide or topical eutectic lidocaine-prilocaine (EMLA) spray reduces pain during hysterosalpingography (HSG) compared with placebo
Description
This randomized, double-blind, placebo-controlled, three-arm clinical trial will evaluate whether oral hyoscine butylbromide or topical eutectic lidocaine-prilocaine (EMLA) spray reduces pain during hysterosalpingography (HSG) compared with placebo
Eligibility
Inclusion Criteria:
- Women undergoing HSG for infertility evaluation
Regular cycles; procedure scheduled in proliferative phase (days 6-12)
Negative urine pregnancy test on procedure day
Exclusion Criteria:
- Known hypersensitivity to hyoscine, lidocaine, prilocaine.
Use of systemic analgesics, sedatives, or antispasmodics within 24 hrs pre-HSG
Chronic pelvic pain or severe dysmenorrhea requiring regular analgesics
Active pelvic infection, uterine anomaly, cervical stenosis requiring anesthesia
History of contrast allergy
Inability to cooperate with VAS reporting